ArticleIn vivo (Athens, Greece)

Determinants of Survival of Ablation Treatment for Portal Vein Tumor Thrombus in Patients With Hepatocellular Carcinoma.

Toru Ishikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.